Bitcoin is growing against the entire crypto market, adding 3% in the last 24 hours. The first cryptocurrency is not only above $9K but is close to reaching $10K.

General Electric (GE) shares have been on the decline as of late. As a result, many investors have been understandably worried. Such sentiments have placed the American manufacturing giant on the market spotlight, and begs the question: is it still worth investing in at current levels? Traversing turbulent market conditions, the outlook seems bleak for the 128-year-old conglomerate. Is there no way up for the aviation unit of General Electric? What about its other subsidiaries? Investor James Richman bets GE is likely to touch down $5-level. From there, the tech investor is bullish that the price will double in value and hit $10 again.Source: Flickr GE: a legacy of over 120 yearsAmid the impact of coronavirus specifically in both travel and hospitality industries, GE's esteemed aviation unit has been feeling the most pressure. The demand for airplanes has shrunk tremendously forcing the company's management to schedule a 25% workforce reduction globally. This is in consonance to the 10% layoff in its US workforce which was announced in March. These difficult cost-cutting measures are deemed necessary by David Joyce, CEO of the GE Aviation Unit that employs a workforce of around 52,000 people.Significant drops since coronavirusGE Aviation supplies jet engines to giant aircraft makers like Airbus and Boeing. The projection of Boeing, a 10% workforce drop amidst its $641m loss, certainly adds up to GE's current woes.  Investor betting on the company bouncing backHowever, one investor who is known to take a different outlook is Latvian-born investor James Richman. With investments in both public and private companies, and his most notable investments including tech giants such as Uber, Tesla, and Facebook, his approach is understood to be contrarian. Yahoo! Finance reports he is taking the opposite approach when compared to Warren Buffet as Richman bets GE's price to temporarily touch upon $5-level. From that level, it is projected to climb its way back to $10, making the 100% rally. The Monaco-based investor has also made headlines when he reportedly pledged $18m in the fight against coronavirus as he mobilizes his biomedical investments in the said efforts. Richman has been historically known to take the contrarian approach in investing. With investments that seemed unorthodox at one point, he has earned respect in the finance field because of his firm's outstanding performance during the 2008 financial crisis. Not open to the general public and mainly dealing with ultra high net worth individuals (UHNWI) and institutional investors, his clients have reported impressive annual earnings for over a decade.Comparison to the last financial crisisIt is not the first time GE had felt the backlash of market recessions. In 2008, the company's shares dropped by 78% tracing the period of the global recession. In 2 years, GE's shares dropped from $27 to $6. The broader S&P also fell that time, but with a conservative 51%.Still worth buying at current levels?GE recovered from the 2008 recession with tremendous momentum. After being bailed out by the federal government to the tune of $139 billion, it experienced an 82% uptick between March 2009 and January 2010. This is more than the 48% bounce back the S&P managed over the same period. Generally, the performance of its stock will still hinge on the developments in the handling of coronavirus pandemic, considering that the aviation division of the company is being hammered as a result. Efforts of which have been showing positive signs of recovery. Meanwhile, the demand for healthcare, government interventions, and the continuous development of treatments and vaccines is seen to help push the shares towards upwards direction in the long run: provided that its wings can weather the storm like it did in 2008.  More recent articles from Smarter Analyst: * RBC: 2 Strong Value Stocks to Buy Now * Look Beyond 2Q, General Motors Will Outperform the Sector, Says Analyst * Coronavirus Vaccine Could Add Massive Value to This Small-Cap Stock, Says Analyst * Can Seanergy Maritime Stock Add 150% Over the Next Year? This Analyst Says 'Yes'

Hey friends, I thought today I’d just spend some time chatting about how life in isolation is really going around here. A brain dump of sorts. Maybe some of it will help you, maybe some of it will entertain you or maybe if nothing else it’ll distract you for at least 5 minutes. Since I […]

If you're seeing Catching Up with Org Junkie ~ How Life in Isolation is Really Going anywhere other than on I'm an Organizing Junkie (or via my email list or a feed reader) it is being used by someone else without my permission. Please let me know, thank you!

Live Online Interactive Stock Analysis Training Wednesday, April 1st, 2020 at 4pm PDT (7pm EDT)

Understanding the types of statistical bias that pop up in popular media and reporting is especially important during this pandemic where the data -- and our global response to the data -- directly impact peoples' lives.

The nationwide tally of confirmed COVID-19 cases reached 59,662 on Saturday and the death toll rose to 1,981 with the country registering an increase of 95 deaths and 3,320 cases in 24 hours till Saturday morning, the Union Health Ministry said

The post India’s COVID-19 tally reaches 59,662, deaths near 2,000; fresh cases among repatriated Indians, paramilitary forces emerges as a major concern appeared first on Firstpost.

Scott Kirsner, author of "Inventing the Movies: Hollywood's Epic Battle Between Innovation and the Status Quo, from Thomas Edison to Steve Jobs."

Joseph Pine and James Gilmore, founders of Strategic Horizons LLP and authors of "Authenticity: What Consumers Really Want."

Barbara Kellerman, lecturer at the Harvard Kennedy School and author of "Followership: How Followers Are Creating Change and Changing Leaders."

Cesare Mainardi, managing director of Booz & Company and coauthor of "Cut Costs, Grow Stronger."

Robert S. Kaplan, Harvard Business School professor and coauthor of the HBR article "How to Solve the Cost Crisis in Health Care."

Sally Ride, former NASA astronaut and founder of Sally Ride Science.

Lisa Rosh, assistant professor of management at the Sy Syms School of Business at Yeshiva University, explains how to build trust through skillful self-disclosure.

The Dilbert creator talks with HBR senior editor Dan McGinn.

Gretchen Rubin, author of "Better than Before: Mastering the Habits of Our Everyday Lives," explains that you've got to know your habit-setting style.

James Bessen, economist and former software executive, on what we can learn from 19th century mill workers about innovation, wages, and technology.

Heidi Grant Halvorson, author of "No One Understands You and What to Do About It" and "9 Things Successful People Do Differently," explains how to actually stick to your resolutions this year.'

Scott Kelly, a retired U.S. astronaut, spent 520 days in space over four missions. Working in outer space is a lot like working on earth, but with different challenges and in closer quarters. Kelly looks back on his 20 years of working for NASA, including being the commander of the International Space Station during his final, yearlong mission. He talks about the kind of cross-cultural collaboration and decision making he honed on the ISS, offering advice that leaders can use in space and on earth. His memoir is “Endurance: A Year in Space, a Lifetime of Discovery.”

Andrew Liveris, the CEO of Dow Chemical, discusses the 120-year-old company’s ambitious sustainability agenda. He says an environmentally driven business model is good for the earth—and the bottom line. Liveris is one of the CEOs contributing to Harvard Business Review’s Future Economy Project, in which leaders detail their company’s efforts to adapt to and mitigate climate change.

Daniel Libeskind, a former academic turned architect and urban designer, discusses his unorthodox career path and repeat success at high-profile, emotionally charged projects. He also talks about his unusual creative process and shares tips for collaborating and managing emotions and expectations of multiple stakeholders. Libeskind was interviewed for the July-August 2018 issue of Harvard Business Review.

Mike Ovitz, a cofounder of Creative Artists Agency and former president of The Walt Disney Company, says there are many parallels between the movie and music industry of the 1970s and 1980s and Silicon Valley today. When it comes to managing creatives, he says you have to have patience and believe in the work. But to get that work made, you have to have shrewd negotiating skills. Ovitz says he now regrets some of the ways he approached business in his earlier years, and advises young entrepreneurs about what he's learned along the way. He's the author of the new memoir "Who Is Michael Ovitz?" Editor's note: This post was updated September 26, 2018 to correct the title of Ovitz's book.

James Detert, a professor at the University of Virginia Darden School of Business, studies acts of courage in the workplace. His most surprising finding? Most people describe everyday actions — not big whistleblower scandals — when they cite courageous (or gutless) acts they’ve seen coworkers and leaders take. Detert shares the proven behaviors of employees who succeed at speaking out and suffer fewer negative consequences for it. He’s the author of the HBR article “Cultivating Everyday Courage.”

Robert Eccles, a visiting professor of management practice at Saïd Business School at the University of Oxford, says that the global investment community's interest in environmental, social, and governance (ESG) issues has finally reached a tipping point. Large asset management firms and pensions funds are now pressuring corporate leaders to improve sustainability practices in material ways that both benefit their firms' bottom line and create broader impact. They're also advocating for more uniform metrics and industry standards. Eccles is the author of the HBR article “The Investor Revolution."

Nancy McKinstry, CEO of Wolters Kluwer, has successfully shifted her company’s business to digital products over 15 years. The Dutch multinational started in the 1830s as a publishing house and now earns more than 90% of its revenue from digital. McKinstry explains how her firm kept investing in product innovation – and how she learned to be patient as consumers slowly adopted new products and services. She also credits the role of increased diversity in her organization. McKinstry is the top woman in HBR’s 2019 list of the world’s best-performing chief executives.

A special thanks to Core77 reader Ross Oliver, who read our post on Cheat Sheets and commented that silicone--which I always thought was inert--may in fact leach harmful chemicals into food.

Oliver provided a link to Life Without Plastic, a company founded in 2006 by two parents seeking alternatives to plastic for their then-newborn child. Today the company sells over 450 products made from nontoxic alternatives to plastic, like good ol' glass and stainless steel. Because they do sell some items that feature silicone gaskets and seals, their website has a section on silicone, where they provide links to several peer-reviewed studies done on how the material reacts with food. Here's some relevant information:

Silicones are not completely inert or chemically unreactive and can release toxic chemicals. They can leach certain synthetic chemicals at low levels, and the leaching is increased with fatty substances, such as oils.

One study tested the release of siloxanes from silicone nipples and bakeware into milk, baby formula and a simulant solution of alcohol and water. Nothing was released into the milk or formula after six hours, but after 72 hours in the alcohol solution several siloxanes were detected.

Another study found siloxanes [a byproduct of the polymerization process used to create a silicone product] being released from silicone bakeware, with leaching increasing as the food fat content increased.

A review of the literature indicated that the key critical effects of common siloxanes, as shown in animal studies, are impaired fertility and potential carcinogenicity (2005 Report by the Danish Ministry of the Environment: Siloxanes - Consumption, Toxicity and Alternatives).

The European Union considers certain siloxanes to be endocrine disruptors (Study on enhancing the Endocrine Disruptor priority list with a focus on low production volume chemicals, ENV.D.4/ETU/2005/00w28r).

If you use silicone in your kitchen, I'd say the entire page is well worth a read.

For tradespeople, farmers and others who frequently need to cover and uncover their shoes (to protect interior surfaces from mud or worse), disposable booties are an unsustainable solution. They're also a pain to take on and off. This reusable and automatically-wrapping design seems much better:

I've been searching for something like this for a long time. On our free-range farm, I inevitably step in the shit of some animal on a daily basis, and pulling my boots off and on every time I need to go back inside to retrieve something gets old.

However, these wouldn't 100% work for my application. While getting them on looks easy, getting them off requires a fair amount of manual manipulation…

…meaning every time I removed these, I'd wind up with animal feces on my hands.

Question for you: How do you reckon these work? I figure inside the fabric is a polypropylene sheet molded into a sprung shape, with raised tunnel-like seams serving as hinges, and when you collapse the tunnels by stepping on them, the spring action is released. [Edit: I believe reader Kyle Lamson has figured it out. See his comment below.]

(Lastly, I was not able to find what company or designer invented these. There are tons of variants on the market. It's possible they were invented by a fellow named Joel Fersaci, whose Step in Sock model is featured in the video above.)

Remember when we used to take airplanes to far away places and stand next to hundreds of strangers all looking at famous sights? I miss that, and I bet you do too. My favorite thing is exploring a new city or country but like so many I’m unable to do it anytime soon. I’ve got

AP Photo/John Minchillo

• The Ohio State University will pay $40.9 million to settle lawsuits brought by 162 men who allege a former university team doctor sexually abused them.
• An independent investigation in 2019 found that Dr. Richard Staruss sexually abused at least 177 students during his tenure from 1979 to 1997.
• The investigation found that OSU personnel had knowledge of allegations against Strauss and repeatedly failed to act.
• Strauss died by suicide in California in 2005.
• Visit Business Insider's homepage for more stories.

The Ohio State University announced on Friday it will pay out $40.9 million as part of a settlement of a combined series of lawsuits brought on by 162 men who said a team doctor who worked at the university for nearly two decades sexually abused them.

"The university of decades ago failed these individuals — our students, alumni and members of the Buckeye community," university President Michael V. Drake said in a statement. "Nothing can undo the wrongs of the past, but we must do what we can today to work toward restorative justice."

See the rest of the story at Business Insider

NOW WATCH: Inside London during COVID-19 lockdown

See Also:

• The best Showtime TV shows of the last decade — and the worst
• Online learning is growing faster than ever — we compared 4 of the top platforms leading the way
• 37 perfect graduation gifts for her — as recommended by a recent college graduate

Jorge Silva/Reuters

• As some countries have started to lift their lockdown measures, public places have been making changes to adapt to government-issued social distancing measures. 
• More public places are using tape, floor markers and plastic dividers to help people comply with social distancing guidelines. 
• Photos show how people are trying to adapt to a new way of life during the coronavirus pandemic.
• Visit Business Insider's homepage for more stories.

As some countries begin to lift their coronavirus lockdown measures, public places have been getting creative to adjust to social distancing guidelines.

From waiters wearing personal protective equipment to schools using plastic dividers between children, these photos show the world is adjusting to life under the coronavirus pandemic.

As countries begin to slowly lift their lockdown measures, many changes have to be made to public life in an effort to prevent second waves of COVID-19.

One of the places that have to adapt the most is restaurants. Some have been coming up with creative ways to enforce social distancing measures, including putting up dividers on tables.

But in some places, a plastic divider is not enough. Diners in this Bangkok restaurant, for example, have been asked to sit diagonally from each other to maximize their distance.

See Also:

• Shanghai Disneyland cast members told to wear face masks and avoid guest contact ahead of next week's reopening as China emerges from pandemic
• A West Virginia worker told us what it was like living at his factory for 28 days to help make PPE, and says he would 'absolutely' do another 'lock-in' to help
• These photos show thousands flocking to New York's parks over the weekend after Mayor de Blasio said that good weather 'is very much a threat to us'

SEE ALSO: LA's skies are smog-free and peacocks are roaming the streets of Dubai. Photos show how nature has returned to cities shut down by the coronavirus pandemic.

AP Photo/Alex Brandon

• The federal government on Saturday announced initial plans for distributing a promising coronavirus drug, remdesivir.
• The drug, manufactured by Gilead Sciences, was authorized for emergency use last week, but doctors and hospitals weren't sure how they were going to get it.
• The Department of Health and Human Services now say the drug is first being distributed to health departments in some hard-hit states, and the departments can distribute it to hospitals as they see fit. 
• Eventually, HHS expects the drug to be delivered to all 50 states, terrorities, the Veterans Health Administration and the Indian Health Service. 
• Visit Business Insider's homepage for more stories.

The federal government released its initial distribution plans today for the promising coronavirus drug, remdesivir, which was approved for emergency use last week. 

The drug, donated by manufacturer Gilead Sciences, "will be used to treat hospitalized COVID-19 patients in areas of the country hardest hit by the pandemic," the US Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response (ASPR) said in a press release.

See the rest of the story at Business Insider

NOW WATCH: How the Navy's largest hospital ship can help with the coronavirus

See Also:

• The coronavirus drug remdesivir was OK'd for emergency use a week ago. The plan to get it to patients is still mired in confusion.
• Dispensed: Hospitals are stuck waiting for a promising coronavirus treatment
• 'It's hard to pay off your medical school loans in this kind of a job': Doctors who can protect the world against pandemics are in short supply

Professional athletes get paid very well for doing a job they love to do.  While athletes make a lot of money compared to the typical individual, athletes’ take-home pay is not nearly as high as advertised. The information we hear… Read More

The post How Much NHL Players Really Make appeared first on Anders CPAs.

While GDC organizers look forward to meeting again in person as soon as possible, this August's GDC Summer will be transformed into an all-digital event in order to best serve our community. ...

They say in SEO you need to use headings. Those can be H1, H2, or even H3 tags. But do they really impact your rankings? Sure, a lot of CMS systems put headings on each of your web pages by default. They do this with the title of the page (or blog post) and sometimes […]

The post Do Headings Really Impact Rankings? appeared first on Neil Patel.

Though the satisfactory resolution of interpersonal conflict is essential, it is the prevention that should be the greater focus.

First Ride: Triumph Tiger 900 Rally Pro & Tiger 900 GT Pro

India Inc gradually inches back to work, here's an industry-wise analysis

Digitally determined businesses are those that have the bigger picture in mind and plan a roadmap towards advanced changes with a view of the entire business.

Martha Curley, RN, PhD, discusses her article in the Mar 2006 issue of Pediatric Critical Care Medicine, titled "State Behavioral Scale: A Sedation Assessment Instrument for Infants and Young Children Supported on Mechanical Ventilation." Dr. Curley, director of nursing research in critical care and cardiovascular nursing research at The Children's Hospital in Boston, Massachusetts, is a recognized expert in pediatric critical care nursing. She discusses the development and validation of the State Behavioral Scale, a tool used in the evaluation of the level of sedation in pediatric patients requiring mechanical ventilation. (Pediatric Care Medicine, Volume 7, Number 2 Mar 2006 pp 107-114)

Steven B. Leder, PhD, discusses his article, Dysphagia Testing and Aspiration Status in Medically Stable Infants Requiring Mechanical Ventilation Via Tracheotomy, published in the July 2010 Pediatric Critical Care Medicine.

Margaret Parker, MD, MCCM, speaks with Guillaume Emeriaud, MD, PhD.

Margaret Parker, MD, MCCM, speaks with Mary Jo C. Grant, APRN, PhD, about the article, Dexmedetomidine Use in Critically-Ill Children with Acute Respiratory Failure, published in the December 2016 issue of Pediatric Critical Care Medicine.

Margaret Parker, MD, MCCM, speaks with Ericka L. Fink, MD, MS, about the PANGEA study (Prevalence of Acute Critical Neurological Disease in Children: A Global Epidemiological Assessment), published in the April 2017 issue of Pediatric Critical Care Medicine.

Margaret Parker, MD, MCCM, speaks with Nilesh M. Mehta, MD, about the article, Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Pediatric Critically Ill Patient: Society of Critical Care Medicine and American Society for Parenteral and Enteral Nutrition, published in the July 2017 issue of Pediatric Critical Care Medicine

Margaret M. Parker, MD, MCCM, speaks with Rakesh Lodha, MD, on his article titled Polyneuropathy in Critically Ill Mechanically Ventilated Children: Experience from Tertiary Care Hospital in North India, published the September issue of Pediatric Critical Care Medicine

Margaret M. Parker, MD, MCCM, speaks with Danny Hames, MD, on his article titled: Risk Factors for Mortality in Critically Ill Children Requiring Renal Replacement Therapy, published in the November 2019 issue of Pediatric Critical Care Medicine.

Margaret M. Parker, MD, MCCM, speaks with Rashid Alobaidi, MD, on his article titled Population-Based Epidemiology and Outcomes of Acute Kidney Injury in Critically Ill Children published in the January 2020 issue of Pediatric Critical Care Medicine.

Gain valuable insight on the clinical management of COVID-19 and its relevance to the pediatric critical care provider with host Elizabeth H. Mack, MD, MS, FCCM, and Jacqueline Ong, MB BChir, MMed (Paeds), MRCPCH